{"nct_id":"NCT02561806","title":"A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis","status":"COMPLETED","status_verified_date":"2020-06","start_date":"2015-10","start_date_type":null,"primary_completion_date":"2016-05","primary_completion_date_type":"ACTUAL","completion_date":"2017-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["LLY"]}